Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Current Taxes (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Current Taxes for 8 consecutive years, with $302000.0 as the latest value for Q4 2025.

  • Quarterly Current Taxes fell 83.73% to $302000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $302000.0 through Dec 2025, down 83.73% year-over-year, with the annual reading at $302000.0 for FY2025, N/A changed from the prior year.
  • Current Taxes for Q4 2025 was $302000.0 at Outlook Therapeutics, roughly flat from $302000.0 in the prior quarter.
  • The five-year high for Current Taxes was $1.9 million in Q4 2024, with the low at $302000.0 in Q3 2025.